Washington Trust’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
DTC
TCM
CC
DM
Washington Trust's DVAX Position: Q1 2025 in Review
Washington Trust sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 3,600 shares — an estimated $46K sold.
Washington Trust first reported a position in DVAX in Q2 2013 and held it in 27 quarters. The position peaked at $69K in Q3 2021. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.
- Washington Trust reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
- Washington Trust sold 3,600 Dynavax Technologies shares in Q1 2025, an estimated $46K.
- Washington Trust first reported a position in Dynavax Technologies in Q2 2013 and held it in 27 quarters.
- Washington Trust's Dynavax Technologies position peaked at $69K in Q3 2021.
- 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.
Based on Washington Trust's 13F filing for Q1 2025, filed 25 Apr 2025.